Trials / Sponsors / Zhuhai Trinomab Pharmaceutical Co., Ltd.

Zhuhai Trinomab Pharmaceutical Co., Ltd.

Industry · 11 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Fo Tetanus	—	2026-01-05
Recruiting	A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following Injury Tetanus	—	2025-07-31
Completed	A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants Respiratory Syncytial Virus Infections	Phase 3	2024-11-28
Unknown	A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjec Varicella	Phase 1	2023-09-12
Completed	A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Respiratory Syncytial Virus Infections	Phase 2 / Phase 3	2023-09-11
Completed	Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immun Tetanus	Phase 3	2022-12-22
Completed	A Study of TNM001 in Chinese Healthy Preterm and Term Infants Respiratory Syncytial Virus Infections	Phase 1 / Phase 2	2022-10-25
Completed	A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Tetanus	Phase 1	2022-08-13
Completed	Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetan Tetanus	Phase 2	2022-04-18
Completed	Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Chinese Healthy Adults Healthy Volunteers	Phase 1	2021-10-15
Completed	Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Healthy Adults Healthy Adult Subjects	Phase 1	2020-11-25